Shimamoto K - Search Results

1

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.

Furuhashi M, Saitoh S, Shimamoto K, Miura T. Furuhashi M, et al. Among authors: shimamoto k. Clin Med Insights Cardiol. 2015 Feb 2;8(Suppl 3):23-33. doi: 10.4137/CMC.S17067. eCollection 2014. Clin Med Insights Cardiol. 2015. PMID: 25674026 Free PMC article. Review.

2

Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.

Okazaki Y, Furuhashi M, Tanaka M, Mita T, Fuseya T, Ishimura S, Watanabe Y, Hoshina K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T. Okazaki Y, et al. Among authors: shimamoto k. PLoS One. 2014 Dec 15;9(12):e115429. doi: 10.1371/journal.pone.0115429. eCollection 2014. PLoS One. 2014. PMID: 25506691 Free PMC article.

3

Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.

Furuhashi M, Omori A, Matsumoto M, Kataoka Y, Tanaka M, Moniwa N, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T. Furuhashi M, et al. Among authors: shimamoto k. Am J Cardiol. 2016 Jul 15;118(2):198-203. doi: 10.1016/j.amjcard.2016.04.037. Epub 2016 May 4. Am J Cardiol. 2016. PMID: 27241838

4

[Treatment for hypertension with metabolic disorders (DM etc)].

Shimamoto K, Miura T. Shimamoto K, et al. Nihon Rinsho. 2006 Aug;64 Suppl 6:513-9. Nihon Rinsho. 2006. PMID: 16981585 Review. Japanese. No abstract available.

5

[Hypertension].

Shimamoto K, Miura T. Shimamoto K, et al. Nihon Rinsho. 2007 Jul 28;65 Suppl 7:537-42. Nihon Rinsho. 2007. PMID: 17824086 Review. Japanese. No abstract available.

6

[Metabolic syndrome].

Shimamoto K, Miura T. Shimamoto K, et al. Nihon Rinsho. 2009 Apr;67(4):771-6. Nihon Rinsho. 2009. PMID: 19348241 Review. Japanese.

7

Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.

Furuhashi M, Ishimura S, Ota H, Hayashi M, Nishitani T, Tanaka M, Yoshida H, Shimamoto K, Hotamisligil GS, Miura T. Furuhashi M, et al. Among authors: shimamoto k. PLoS One. 2011;6(11):e27356. doi: 10.1371/journal.pone.0027356. Epub 2011 Nov 10. PLoS One. 2011. PMID: 22102888 Free PMC article.

8

Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.

Ota H, Furuhashi M, Ishimura S, Koyama M, Okazaki Y, Mita T, Fuseya T, Yamashita T, Tanaka M, Yoshida H, Shimamoto K, Miura T. Ota H, et al. Among authors: shimamoto k. Am J Hypertens. 2012 Oct;25(10):1124-30. doi: 10.1038/ajh.2012.88. Epub 2012 Jun 21. Am J Hypertens. 2012. PMID: 22717543 Free PMC article.

9

[Molecular targeted therapy for hypertension and cardiovascular diseases].

Akasaka H, Miura T, Shimamoto K. Akasaka H, et al. Among authors: shimamoto k. Nihon Rinsho. 2012 Nov;70 Suppl 8:593-6. Nihon Rinsho. 2012. PMID: 23513908 Japanese. No abstract available.

10

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.

Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, Ishimura S, Watanabe Y, Hoshina K, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T. Fuseya T, et al. Among authors: shimamoto k. Cardiovasc Diabetol. 2014 Aug 21;13:126. doi: 10.1186/s12933-014-0126-7. Cardiovasc Diabetol. 2014. PMID: 25142635 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,185 results

Search Page